Directory

>

Paulo Falabella Md

avatar

Paulo Falabella Md

Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases | REGENXBIO

Washington, District of Columbia, United States

View contact details (it's free)

Paulo Falabella Md

Summary

Paulo Falabella is a seasoned life sciences executive with a robust clinical and scientific background, specializing in advanced therapies and drug commercialization. He has played a pivotal role in the development and launch of groundbreaking gene therapies, notably LUXTURNA, the first FDA-approved gene therapy for a genetic disease in the U.S. His extensive experience spans multiple therapeutic areas, including CNS and ocular disorders, showcasing his versatility in the biotech landscape. Paulo has held significant leadership positions in reputable organizations such as REGENXBIO and Spark Therapeutics, where he has driven clinical development and patient advocacy initiatives. His academic credentials include a PhD in Cell-Based Therapies and an MBA from Harvard Business School, underscoring his commitment to merging scientific innovation with strategic business acumen. Paulo's passion for ophthalmology and regenerative medicine positions him at the forefront of transformative healthcare solutions.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Paulo Falabella Md

Work Experience

company logo

Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases at

REGENXBIO

February 2019 - Present

company logo

VP, Medical Strategy Lead - Ophthalmology | Rare Diseases at

Spark Therapeutics, Inc.

January 2018 - January 2019

company logo

Global Medical Director, Ophthalmology | Rare Diseases at

Spark Therapeutics, Inc.

January 2015 - October 2018

💼

Biotechnology/Pharmaceutical Consultant at

GRACE PHARMA MEDICAL STORE

January 2013 - January 2015

💼

Medical | Surgical Retina Specialist at

Lambert Oftalmologistas

February 2011 - January 2013

company logo

Assistant Professor of Ophthalmology - Retina | Cataract at

Cvintal Oftalmologia

January 2010 - January 2013

company logo

Coordinator of Ophthalmology Department at

Cvintal Oftalmologia

January 2011 - January 2012

Paulo Falabella Md

Education

HBX | Harvard Business School, Core - Credential Of Readiness

January 2018 - January 2018

Universidade Federal de São Paulo, Phd - Cell-Based Therapies And Artificial Vision (Retinal Electrical Stimulation)

January 2013 - January 2018

University of Southern California, Postdoctoral Research Associate

January 2013 - January 2015

Universidade Federal de São Paulo, Ocular Bioengineering Fellowship

Instituto de Oftalmologia Tadeu Cvintal, Clinical And Surgical Fellowship In Vitreoretinal Diseases

Instituto de Oftalmologia Tadeu Cvintal, Ophthalmology Residency

Federal University of Juiz de Fora, Doctor Of Medicine (M.D.)

Frequently Asked Questions about Paulo Falabella Md

What is Paulo Falabella Md email address?

Paulo Falabella Md's primary email address is ****************@fb.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Paulo Falabella Md work for?

Paulo Falabella Md is a Vice President - Clinical Development & Operations, Patient Advocacy | Rare Diseases at REGENXBIO, a company specializing in Commercial physical research.

Where Paulo Falabella Md graduated from?

Paulo Falabella Md holds a degree in Business Administration And Management, General from HBX | Harvard Business School.

How can I directly contact Paulo Falabella Md?

To contact Paulo Falabella Md directly, you can use the email address ****************@fb.com. Complete contact information is available upon registration with Muraena.

Who is Paulo Falabella Md?

Paulo Falabella is a seasoned life sciences executive with a robust clinical and scientific background, specializing in advanced therapies and drug commercialization. He has played a pivotal role in the development and launch of groundbreaking gene therapies, notably LUXTURNA, the first FDA-approved gene therapy for a genetic disease in the U.S. His extensive experience spans multiple therapeutic areas, including CNS and ocular disorders, showcasing his versatility in the biotech landscape. Paulo has held significant leadership positions in reputable organizations such as REGENXBIO and Spark Therapeutics, where he has driven clinical development and patient advocacy initiatives. His academic credentials include a PhD in Cell-Based Therapies and an MBA from Harvard Business School, underscoring his commitment to merging scientific innovation with strategic business acumen. Paulo's passion for ophthalmology and regenerative medicine positions him at the forefront of transformative healthcare solutions.

Paulo`s contact details

mail

****************@fb.com

**********@regenxbio.com

Colleagues

avatar
Steve Pakola Md

Chief Medical Officer

avatar
Sumie Takahara

Executive Director, Global Product and Market Planning

avatar
Kim Pack

Executive Director Drug Delivery & Training

avatar
Sarah Thomas

Sr Vice President, Quality

avatar
Niall Carolan

Senior Vice President, Global Program Management & Alliance Management

avatar
Stacey Curtiss

Vice President, Medical Affairs

avatar
Sherri Van Everen

Vice President, Ophthalmology Clinical Development

avatar
Shiva Fritsch

Chief Communications & People Officer

avatar
Dabt Justine Cunningham

VP, Nonclinical Development

avatar
Kirsten Cowley

Executive Director Clinical Operations

View Contact details (it's free)
Request Profile Removal